5 minutes with Practice Manager Sherrie D'Souza
15 May 2015
Practice Manager of six over two locations, Sherrie D’Souza is a highly valued staff member at MIA. We sat down with her to get some insight into a day in the life of her role and what inspires her.
Can you tell us a bit about your role?
I am the Practice Manager of six, over two locations, MIA and RPA as well as 17 Doctors across both those locations as well. I supervise the administrative management of the clinics at these locations including staffing, finance and other practice matters.
What drives you to come to work?
The opportunity to make life a little bit easier for our patients and if we can put a smile on their faces, as secretaries that is a great day.
How do you stay positive?
It is easy to stay positive because our patients are positive. They have a fierce positivity that doesn’t show any boundaries, there is no way we can be negative when we are seeing such amazing results. How far the research has come also inspires such positivity as we can see how we are changing lives daily.
Explain the team environment within the clinic
The Doctors are incredible and passionate and happy to share their knowledge and foster an environment of learning. The secretaries are feeding off the energy, they give that bit extra and I am lucky to work with such an incredible team, it is so enjoyable to work with such great people. It doesn’t feel like a job to me, it is my life and I love it.
What do you like to do in your spare time?
I love spending time with my husband and my cat; I also love my hobbies like cross-stitch. I like to have lots going on, I don’t like having idle hands, and I am always looking for my next project to do!
“I had a complete response within about six months. All of my tumours disappeared."
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.